JENNIFER MCCULLUGH: Open Payments
NPI 1619290947 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 49 payments from 10 companies in 2025. Trend: 2023 $1,503 · 2024 $491 · 2025 $897
Food & beverage: $887Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $269 |
| Janssen Biotech, Inc. | 20 | $235 |
| Organon LLC | 11 | $158 |
| UCB, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| REVANCE THERAPEUTICS, INC. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: SKYRIZI, TREMFYA, HADLIMA, Bimzelx, DAXXIFY, DUPIXENT, COSENTYX, Rhapsido.
Industry payments across WA — which companies pay providers there.
